Review of olanzapine in the management of bipolar disorders

References

• [ADA] American Diabetes Association2004Consensus development and conference on antipsychotic drugs and obesity and diabetesDiabetes Care2759660114747245
   PubMed Web of Science ®Google Scholar
• [APA] American Psychiatric Association2002Practice guidelines for the treatment of patients with bipolar disorder (revision)Am J Psychiatry159Suppl 4150
   Web of Science ®Google Scholar
• [APA] American Psychiatric Association2006Practice guideline for the treatment of patients with bipolar disorder second edition [online]Accessed Nov 24, 2006 URL: http://www.psych.org
   Google Scholar
• AtkinsonMZibinSChuangH1997Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodologyAm J Psychiatry154991058988966
   PubMed Web of Science ®Google Scholar
• BakerRWKinonBJMaguireGA2003Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitationJ Clin Psychopharmacol23342812920409
   PubMed Web of Science ®Google Scholar
• BakerRWTohenMFawcettJ2003Acute dysphoric mania: treatment response to olanzapine versus placeboJ Clin Psychopharmacol23132712640214
   PubMed Web of Science ®Google Scholar
• BarakYSwartzMPlopskyI2005Assessing cardiovascular risks of olanzapine treatment: a 6-month study versus haloperidol in schizophrenia patientsInt Clin Psychopharmacol203151716192840
   PubMed Web of Science ®Google Scholar
• BasuRBrarJSChengappaKN2004The prevalence of the metabolic syndrome in patients with schizoaffective disorder – bipolar subtypeBipolar Disord63141815225149
   PubMed Web of Science ®Google Scholar
• BerkMIchimLBrookS1999Olanzapine compared to lithium in mania: a double-blind randomized controlled trialInternational Clinical Psychopharmacology143394310565800
   PubMed Web of Science ®Google Scholar
• BowdenCL2003Acute and maintenance treatment with mood stabilizersInt J Neuropsychopharmacol626975 Review Journal of Affective Disorders 67, 2001, 257–65[TC3]12974993
   PubMed Web of Science ®Google Scholar
• BrownEBMcElroySLKeckPEJr2006A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar i depressionJournal of Clinical Psychiatry6710253316889444
   PubMed Web of Science ®Google Scholar
• BrownJBNicholsGAGlauberHS1999Ten-year follow-up of antidiabetic drug use, nonadherence, and mortality in a defined population with type 2 diabetes mellitusClin Ther2110455710440626
   PubMed Web of Science ®Google Scholar
• BymasterFPRasmussenKCalligaroDO1997In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drugJournal of Clinical Psychiatry58Suppl 1028369265914
   PubMed Web of Science ®Google Scholar
• CallaghanJTBergstromRFPtakLR1999Olanzapine: pharmacokinetic and pharmacodynamic profileClinical Pharmacokinetics371779310511917
   PubMed Web of Science ®Google Scholar
• CaseyDE1997The relation of pharmacology to side effectsJ Clin Psychiatry58Suppl 1055629265918
   PubMed Web of Science ®Google Scholar
• deLeonJArmstrongSCCozzaKL2005The dosing of atypical antipsychoticsPsychosomatics462627315883149
   PubMed Web of Science ®Google Scholar
• DoucetteDEGrenierJPRobertsonPS2000Olanzapine-induced acute pancreatitisThe Annals of Pharmacotherapy3411283111054978
   PubMed Web of Science ®Google Scholar
• FagioliniAKupferDJHouckPR2003Obesity as a correlate of outcome in patients with bipolar I disorderAm J Psychiatry1601121712505809
   PubMed Web of Science ®Google Scholar
• FagioliniAFrankEScottJA2005Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for PennsylvaniansBipolar Disord74243016176435
   PubMed Web of Science ®Google Scholar
• GoffDCSullivanLMMcEvoyJP2005A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controlsSchizophr Res80455316198088
   PubMed Web of Science ®Google Scholar
• GorobetsLN2005Effect of therapy with atypical antipsychotic drugs on prolactin concentration in patients with schizophrenia and schizoaffective disordersBull Exp Biol Med1407141516848233
   PubMed Web of Science ®Google Scholar
• HirschfieldRMLewisLVornikLA2003Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorderJ Clin Psychiatry641617412633125
   PubMed Web of Science ®Google Scholar
• KassahunKMattiuzENyhartE1997Disposition and biotransformation of the antipsychotic agent olanzapine in humansDrug Metab Dispos2581939010634
   PubMed Web of Science ®Google Scholar
• KeckPEJrPerlisRHOttoMW2004Expert consensus guideline series: treatment of bipolar disorder 2004Postgraduate Med Special Report12112o
   Google Scholar
• KesslerRCRubinowDRHolmesC1997The epidemiology of DSM-III-R bipolar I disorder in a general population surveyPsychol Med271079899300513
   PubMed Web of Science ®Google Scholar
• KrebsMLeopoldKHinzpeterA2006Current schizophrenia drugs: efficacy and side effectsExpert Opin Pharmacother710051616722811
   PubMed Web of Science ®Google Scholar
• LipkovichICitromeLPerlisR2006Early predictors of substantial weight gain in bipolar patients treated with olanzapineJ Clin Psychopharmacol263162016702898
   PubMed Web of Science ®Google Scholar
• MasandPSCulpepperLHendersonD2005Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilizationCNS Spectr10Suppl 14115
   Google Scholar
• McElroySLFryeMASuppesT2002Correlates of overweight and obesity in 644 patients with bipolar disorderJ Clin Psychiatry632071311926719
   PubMed Web of Science ®Google Scholar
• MiklowitzDJ2006An update on the role of psychotherapy in the management of bipolar disorderCurr Psychiatry Rep849850317094929
   PubMedGoogle Scholar
• NamjoshiMABueschingDP2001A review of the health-related quality of life literature in bipolar disorderQual Life Res101051511642680
   PubMed Web of Science ®Google Scholar
• NamjoshiMARajamannarGJacobsT2002Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania. Results from a randomized controlled trialJ Affect Disord691091812103458
   PubMed Web of Science ®Google Scholar
• Ness-AbramofRApovianCM2005Drug-induced weight gainDrugs Today (Barc)4154755 Review16234878
   PubMed Web of Science ®Google Scholar
• NewcomerJW2005Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature reviewCNS Drugs19Suppl 1193 Review15998156
   PubMed Web of Science ®Google Scholar
• NierenbergAAIstacherMJCalabreseJR2006Treatment resistant bipolar depression. A STEP-BD equipoise randomized effectiveness trail of antidepressant augmentation with lamotrigine, inositol or risperidoneAm J Psychiatry1632101616449473
   PubMed Web of Science ®Google Scholar
• RevickiDAMatzaLSFloodE2005Bipolar disorder and health-related quality of life: review of burden of disease and clinical trialsPharmacoeconomics2358394 Review15960554
   PubMed Web of Science ®Google Scholar
• RushAJTrivediMHWisniewskiSR2006Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D reportAm J Psychiatry16319051717074942
   PubMed Web of Science ®Google Scholar
• ShiLNamjoshiMAZhangF2002Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work statusInt Clin Psychopharmacol172273712177585
   PubMed Web of Science ®Google Scholar
• SuppesTDennehyEBHirschfeldRM2005The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorderJournal of Clinical Psychiatry668708616013903
   PubMed Web of Science ®Google Scholar
• TohenMBakerRWAltshulerLL2002Olanzapine versus divalproex in the treatment of acute maniaAmerican Journal of Psychiatry15910111712042191
   PubMed Web of Science ®Google Scholar
• TohenMCalabreseJRSachsGS2006Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapineAm J Psychiatry1632475616449478
   PubMed Web of Science ®Google Scholar
• TohenMChengappaKNSuppesT2002Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapyArch Gen Psychiatry5962911779284
   PubMed Web of Science ®Google Scholar
• TohenMChengappaKNSuppesT2004Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser aloneBritish Journal of Psychiatry1843374515056579
   PubMed Web of Science ®Google Scholar
• TohenMGoldbergJFArrillagaAM2003A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute maniaArchives of General of Psychiatry60121826
   PubMed Web of Science ®Google Scholar
• TohenMGreilWCalabreseJR2005Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trialAmerican Journal of Psychiatry16212819015994710
   PubMed Web of Science ®Google Scholar
• TohenMJacobsTGGrundySL2000Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled studyArchives of General Psychiatry57841910986547
   PubMed Web of Science ®Google Scholar
• TohenMKetterTAZarateCA2003Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week studyAmerican Journal of Psychiatry16012637112832240
   PubMed Web of Science ®Google Scholar
• TohenMSangerTMMcElroySL1999Olanzapine versus placebo in the treatment of acute maniaAmerican Journal of Psychiatry156702910327902
   PubMed Web of Science ®Google Scholar
• TohenMVietaECalabreseJ2003Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depressionArchives of General Psychiatry6010798814609883
   PubMed Web of Science ®Google Scholar
• TollefsonGDBeasleyCMJrTranPV1997Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trialAm J Psychiatry154457659090331
   PubMed Web of Science ®Google Scholar
• VojtaCKinosianBGlickH2001Self-reported quality of life across mood states in bipolar disorderCompr Psychiatry42190511349236
   PubMed Web of Science ®Google Scholar
• WaageCCarlssonHNielsenEW2004Olanzapine-induced pancreatitis: a case reportJOP J Pancreas (Online)538891
   PubMedGoogle Scholar
• ZajeckaJMWeislerRSachsG2002A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorderJournal of Clinical Psychiatry6311485512523875
   PubMed Web of Science ®Google Scholar